Izidore Lossos

Professor

  • 16981 Citations
1988 …2024
If you made any changes in Pure, your changes will be visible here soon.

Fingerprint Dive into the research topics where Izidore Lossos is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 18 Similar Profiles
Lymphoma, Large B-Cell, Diffuse Medicine & Life Sciences
Lymphoma Medicine & Life Sciences
Germinal Center Medicine & Life Sciences
Non-Hodgkin's Lymphoma Medicine & Life Sciences
B-Lymphocytes Medicine & Life Sciences
Cells Chemical Compounds
Follicular Lymphoma Medicine & Life Sciences
B-Cell Lymphoma Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Projects 2004 2024

Lymphoma, Large B-Cell, Diffuse
Homologous Recombination
Adenosine Diphosphate Ribose
Therapeutics
Recombinational DNA Repair
Lymphoma, Large B-Cell, Diffuse
Paraffin
RNA
Biomarkers
Gene Expression
Germinal Center
Lymphoma
Lymphoma, Large B-Cell, Diffuse
Myosin Type II
Interleukin-4

Research Output 1988 2019

  • 16981 Citations
  • 270 Article
  • 2 Comment/debate
  • 2 Review article
  • 1 Chapter
1 Citation (Scopus)
Methotrexate
Lymphoma
Radiotherapy
Drug Therapy
Brain

Central nervous system emergencies in haematological malignancies

De La Fuente, M. I., Alderuccio, J. P. & Lossos, I., Jan 1 2019, (Accepted/In press) In : British Journal of Haematology.

Research output: Contribution to journalReview article

Hematologic Neoplasms
Emergencies
Central Nervous System
Leukostasis
Central Nervous System Infections

Interplay between HGAL and Grb2 proteins regulates B-cell receptor signaling

Jiang, X., Lu, X., Zhang, Y., Lacaria, L., Schuchardt, B. J., Mikles, D. C., Magistri, M., García-Ramírez, I., Sanchez-Garcia, I., Farooq, A., Verdun, R. E., Abdulreda, M. H., Moy, V. T. & Lossos, I., Aug 13 2019, In : Blood Advances. 3, 15, p. 2286-2297 12 p.

Research output: Contribution to journalArticle

Open Access
GRB2 Adaptor Protein
B-Lymphocytes
Germinal Center
Binding Sites
Phosphopeptides
1 Citation (Scopus)

LMO2 Confers Synthetic Lethality to PARP Inhibition in DLBCL

Parvin, S., Ramirez-Labrada, A., Aumann, S., Lu, X. Q., Weich, N., Santiago, G., Cortizas, E. M., Sharabi, E., Zhang, Y., Sanchez-Garcia, I., Gentles, A. J., Roberts, E., Bilbao-Cortes, D., Vega, F., Chapman-Fredricks, J., Verdun, R. E. & Lossos, I., Sep 16 2019, In : Cancer Cell. 36, 3, p. 237-249.e6

Research output: Contribution to journalArticle

Poly(ADP-ribose) Polymerases
Lymphoma, Large B-Cell, Diffuse
T-Cell Lymphoma
Homologous Recombination
Precursor Cell Lymphoblastic Leukemia-Lymphoma
2 Citations (Scopus)

Maintenance rituximab or observation after frontline treatment with bendamustine-rituximab for follicular lymphoma

Hill, B. T., Nastoupil, L., Winter, A. M., Becnel, M. R., Cerhan, J. R., Habermann, T. M., Link, B. K., Maurer, M. J., Fakhri, B., Reddy, P., Smith, S. D., Mukhija, D., Jagadeesh, D., Desai, A., Alderuccio, J. P., Lossos, I., Mehra, P., Portell, C. A., Goldman, M. L., Calzada, O. & 9 others, Cohen, J. B., Hussain, M. J., Ghosh, N., Caimi, P., Tiutan, T., Martin, P., Kodali, A., Evens, A. M. & Kahl, B. S., Feb 1 2019, In : British Journal of Haematology. 184, 4, p. 524-535 12 p.

Research output: Contribution to journalArticle

Follicular Lymphoma
Maintenance
Observation
Therapeutics
Vincristine